1. Home
  2. MLYS vs WASH Comparison

MLYS vs WASH Comparison

Compare MLYS & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • WASH
  • Stock Information
  • Founded
  • MLYS 2019
  • WASH 1800
  • Country
  • MLYS United States
  • WASH United States
  • Employees
  • MLYS N/A
  • WASH N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • WASH Major Banks
  • Sector
  • MLYS Health Care
  • WASH Finance
  • Exchange
  • MLYS Nasdaq
  • WASH Nasdaq
  • Market Cap
  • MLYS 890.6M
  • WASH 540.4M
  • IPO Year
  • MLYS 2023
  • WASH N/A
  • Fundamental
  • Price
  • MLYS $39.49
  • WASH $29.75
  • Analyst Decision
  • MLYS Strong Buy
  • WASH Buy
  • Analyst Count
  • MLYS 6
  • WASH 4
  • Target Price
  • MLYS $42.60
  • WASH $32.25
  • AVG Volume (30 Days)
  • MLYS 2.6M
  • WASH 108.0K
  • Earning Date
  • MLYS 11-10-2025
  • WASH 10-20-2025
  • Dividend Yield
  • MLYS N/A
  • WASH 7.64%
  • EPS Growth
  • MLYS N/A
  • WASH N/A
  • EPS
  • MLYS N/A
  • WASH N/A
  • Revenue
  • MLYS N/A
  • WASH $116,006,000.00
  • Revenue This Year
  • MLYS N/A
  • WASH $57.40
  • Revenue Next Year
  • MLYS N/A
  • WASH $9.62
  • P/E Ratio
  • MLYS N/A
  • WASH N/A
  • Revenue Growth
  • MLYS N/A
  • WASH N/A
  • 52 Week Low
  • MLYS $8.24
  • WASH $24.95
  • 52 Week High
  • MLYS $39.20
  • WASH $40.59
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 84.85
  • WASH 54.30
  • Support Level
  • MLYS $34.59
  • WASH $28.64
  • Resistance Level
  • MLYS $39.20
  • WASH $30.19
  • Average True Range (ATR)
  • MLYS 2.98
  • WASH 0.66
  • MACD
  • MLYS 0.59
  • WASH -0.13
  • Stochastic Oscillator
  • MLYS 99.57
  • WASH 51.20

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

Share on Social Networks: